EQS Newsfeed

Corpare News, Press, Analysis

Made with ❤ von BGFL
#BGFLapp * beta

EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.

04.12.2025 06:53PM

Outlook for fiscal year 2026 and update of mid-term guidance

SCHOTT Pharma: Outlook for fiscal year 2026 and update of mid-term guidance Today, SCHOTT Pharma issues its financial guidance for fiscal year 2026: The company expects revenue growth at constant currencies in the range of 2-5% and an EBITDA margin of around 27%. This projection deviates from current market expectations (source: Vara consensus as o [ … ]
04.12.2025 04:35PM

Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors

Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors Trostberg, December 4, 2025 – Alzchem Group AG, a globally active specialty chemicals company, has approved a comprehensive investment program to achieve additional profitable growth and further strengthen its marke [ … ]
04.12.2025 04:21PM

Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products

Trostberg, December 4, 2025 – Alzchem Group AG approved a comprehensive investment program for further capacity expansion in creatine products. The focus is particularly on the application areas of health, nutrition, and pharmaceuticals. In total, around 120 million euros will be invested in the construction of a new, increasingly automated product [ … ]
04.12.2025 08:30AM

Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome

  Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndrome Milestone payment to Evotec expected upon first dosing of first study participant in early 2026   Hamburg, Germany, 04 December 2025: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 56 [ … ]
04.12.2025 06:30AM

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region

Presse Release // December 04, 2025   Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region   Planegg-Martinsried, Germany / Amman, Jordan – Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and suppl [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
If desired, the news can be limited to certain indices (DAX, MDAX, etc.) or market segments (Prime Standard, General Standard, Scale, etc.).
Dataselect Tool Family
          EQS Newsfeed          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL